Vertex Pharmaceuticals Additions for tax positions of prior years remained flat by 0.0% to $1.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.0%, from $1.15M to $1.30M. Over 2 years (FY 2023 to FY 2025), Additions for tax positions of prior years shows a downward trend with a -71.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may signal potential tax audit risks or unfavorable adjustments to historical tax filings.
Reflects the increase in unrecognized tax benefits liability attributable to tax positions taken in prior reporting peri...
Commonly found in the 'Rollforward of Unrecognized Tax Benefits' table in corporate tax disclosures.
other_unrecognized_tax_benefits_increases_resulting_from_bb8d5f| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $62.50M | $4.60M | $5.20M |
| YoY Change | — | -92.6% | +13.0% |